The Defense Logistics Agency (DLA) awarded a $4,518.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of ABRYSVO vials with diluent syringes. This contract, which has a completion date of November 13, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This delivery order does not have a set-aside designation, indicating open competition.
Generated 2/11/25, 10:24 AM